Haleon among bidders for supplements maker Thorne, sources say

By Abigail Summerville, ‌Richa Naidu and ​Amy-Jo ​Crowley

June 26 (Reuters) - Consumer health company Haleon bid for U.S. supplements firm Thorne, sources said on ‌Friday, at a time when Haleon has been ⁠hoping to expand in the roughly $70 billion U.S. supplements market.

Thorne, which ‌LVMH-backed private equity firm ‌L Catterton acquired for $680 million in 2023, has been exploring a sale with investment bankers and attracted strategic ​interest, including a bid from Haleon, two people familiar with the matter told Reuters.

Thorne, which sells dietary ⁠supplements including magnesium and omega-3, primarily in the United States, declined to comment. ​A spokesperson for Haleon, maker of Advil and Centrum vitamins, said the company did not ​comment on rumour or speculation. ‌L Catterton did not immediately respond to a request for comment.

Three sources said consumer goods ⁠company Unilever did not bid for Thorne. Unilever has been shifting towards beauty and wellbeing brands under CEO Fernando Fernandez.

The ⁠Financial Times reported earlier on Friday that Unilever was among several ​bidders for South Carolina-based Thorne. The FT said Thorne was valued at up to $4 billion.

Unilever declined to comment.

Grand View Research estimated ‌the U.S. dietary supplements market at $68.74 billion in 2025 and projected it would reach $131.08 billion ‌by 2033

(Reporting by Nithyashree R B, Rishab Shaju and ⁠Unnamalai L in Bengaluru, ‌Abigail Summerville in ​New York and Richa Naidu in London; Editing by Devika Syamnath, Tomasz Janowski, David Gregorio, Rod ‌Nickel)

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Factbox-Where authorities are restricting data centres amid AI boom
• Several dead in fire at Brussels construction site, authorities say
• SLB partners with Liberty Energy to supply modular parts, power to data centers